Subscribe To
Usd/jpy weekly outlook
USD/JPY retreated steeply after edging higher to 151.69 last week. But downside is contained above 148.79 support so far. Initial bias remains neutral...
November 4, 2023, 2:23 pm
Eur/jpy weekly outlook
EUR/JPY’s up trend resumed last week and hit 160.84 before turning into consolidation. Initial bias stays neutral this week as more sideway trading ...
November 4, 2023, 1:16 pm
Nie: discounted but not a bargain
The Virtus Equity & Convertible Income Fund is benefiting from its heavy exposure to mega-cap tech stocks, leading to a...
November 4, 2023, 9:45 am
A once-in-a-decade investment opportunity: 1 magnificent growth stock to buy now and hold forever
Paycom reported solid third-quarter financial results, but the stock crashed on weak guidance. Paycom b...
November 4, 2023, 6:53 am
This 7.6%-yielding dividend stock showcases why it's a no-brainer for income
Enbridge continues to deliver solid results. The company's financial metrics are at the low end of its ...
November 4, 2023, 6:27 am
10x genomics: unveiling the investment potential
10x Genomics is a life science technology company with a clear mission and visionary leadership. 10x Genomics delivered a...
November 4, 2023, 1:02 am
Seacor marine: good company, but not good enough
The OSV market is expected to face a deficit due to low order book levels and declining shipyard capacity, but growing demand from deep-water protects...
November 4, 2023, 12:05 am
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Usd / cad – canadian dollar counting down to employment reports.
(MENAFN- Baystreet) USD / CAD – Canadian dollar counting down to employment reports. – US NFP expected to rise by 180,000. – Canada LFS forecast...
November 3, 2023, 11:29 pm
Vox: high-beta on once again after fed pause, forward earnings projections
The Federal Reserve's decision to hold the policy rate steady is a potential bullish turning point for US equities. The communication services sector ...
November 3, 2023, 9:30 pm
Kineta reports third quarter 2023 financial results and provides corporate update
Announced positive KVA12123 monotherapy safety data from its ongoing phase 1/2 VISTA-101 clinical trial Enrolled the first patient of KVA12123 in comb...
November 3, 2023, 8:01 pm
Why roku stock blasted nearly 9% higher on friday
In the wake of a solid earnings report, a pair of analysts became more bullish on the stock. They both ...
November 3, 2023, 6:19 pm
Barrick gold corporation: barrick gold earnings: solid, driven by increased gold sales volumes and prices
Find the latest Barrick Gold Corporation (GOLD) stock forecast based on top analyst’s estimates, plus more investing and trading data from Yahoo Fin...
November 3, 2023, 4:14 pm
Occidental (oxy) to report q3 earnings: what's in the offing?
Occidental's (OXY) third-quarter earnings are to be driven by solid production from its Permian assets,...
November 3, 2023, 3:47 pm
Gibraltar (rock) q3 earnings & net sales beat, stock up
Gibraltar's (ROCK) third-quarter earnings gain from solid execution in all its operating segments....
November 3, 2023, 3:47 pm
Bill holdings (bill) q1 earnings top estimates, revenues up y/y
BILL Holdings' (BILL) first-quarter fiscal 2024 results reflect solid growth in total payment volume an...
November 3, 2023, 3:02 pm
Bce's q3 earnings match estimates, revenues increase y/y
BCE's third-quarter performance gains from solid residential Internet growth and higher Bell CTS sales....
November 3, 2023, 2:17 pm